This week marks the beginning of spring and National Asthma Week, a time when the National Asthma Council (NAC) urges Australians with asthma to...
Pharmacists can minimise opioid harm by helping patients step down.
While opioids play an important role in the management of acute pain, their widespread use...
The Therapeutic Goods Administration (TGA) has made a final decision on the rescheduling of modified release (MR) paracetamol due to safety concerns.
The safety of...
Symbicort prn is now indicated to treat mild asthma flare-ups after an extended indication was approved by the TGA.
Symbicort Turbuhaler and Rapihaler are now...
As the saying goes, ‘You’ve got to know when to hold ’em, and know when to fold ’em.’
Complementary medicines may also be called ‘traditional’...
With the fast-approaching 30 September marking the end of the current CPD year, pharmacists should take stock of the progress of their CPD plans....
Methaqualone was one of the most abused prescription drugs worldwide during the 1970s. Thankfully, the world woke up to its destructive capacity.
Methaqualone was first...
This evidence summary presents the best available evidence regarding the efficacy and safety of a combination of antidepressants and benzodiazepines for adults with major...
Pharmacists play a vital role supporting patients with chronic pain.
Around 1 in 5 Australians experience chronic pain; this rises to 1 in 3...
The CEO of Diabetes Australia, Professor Greg Johnson, recently called attention to the high numbers of Australians living with undiagnosed type 2 diabetes.
In a...
